Cohort study on HIV prevention in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Dat'Aids Prevention is a cohort study that investigates various aspects of HIV prevention across over 23 sites in France, including overseas locations. The study focuses on HIV screening, STI and hepatitis screening, as well as post-exposure and pre-exposure prophylaxis. By gathering data from individuals attending these services, the study aims to provide a comprehensive overview of current HIV prevention strategies and their effectiveness. Participants will be monitored to assess the impact of these interventions on HIV prevention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male and female over 18 years old,
* HIV negative
* Attending for :
* HIV screening
* Hepatitis screening
* STI screening / treatment
* Blood, body fluid or sexual exposure
* Post-exposure prophylaxis
* Pre-exposure prophylaxis
* Signed consent

Exclusion Criteria:

* HIV-infection
* Refusal to participate

Where it's running

• Hôpital Nord Franche Comté
  Belfort, France Recruiting
• CHU Besançon - Hôpital Jean Minjoz
  Besançon, France Recruiting
• CHRU Brest
  Brest, France Recruiting
• CHU Clermont-Ferrand - Hôpital Gabriel-Montpied
  Clermont-Ferrand, France Recruiting
• CHD Vendée
  La Roche-sur-Yon, France Recruiting
• Hôpital Bicêtre - Assistance Publique des Hôpitaux de Paris
  Le Kremlin-Bicêtre, France Recruiting

Study contacts

• Principal investigator: Pascal PUGLIESE, MD — Centre Hospitalier Universitaire de Nice
• Study coordinator: Pascal Pugliese, MD
• Email: pugliese.p@chu-nice.fr
• Phone: 0033492035802

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pharmacist-guided PEP/PrEP Access Using PEPPI Software

  This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.

  Recruiting Empowerx INC · Del Mar, California · NCT07683117

• Feasibility of Online HIV Prevention Research for People Who Inject Drugs

  This study tests whether online recruitment and at-home HIV testing can be done reliably by and for people who inject drugs.

  Recruiting Montefiore Medical Center · The Bronx, New York · NCT07625917

• Host-led harm reduction for men who have sex with men who engage in chemsex in Bangkok

  This project will try a host-led harm reduction approach to reduce substance-related, sexual, mental health, and legal harms among men who have sex with men who engage in chemsex in Bangkok.

  Recruiting Institute of HIV Research and Innovation Foundation, Thailand · Pathum Wan, Bangkok · NCT07512869

• Transgender-tailored harm reduction and PrEP service for people who engage in chemsex in Bangkok

  This project will try a comprehensive harm-reduction service tailored for transgender and non-binary adults in Bangkok who engage in chemsex or substance use to increase PrEP use, reduce HIV/STIs, and address mental health and socio-legal needs.

  Recruiting Institute of HIV Research and Innovation Foundation, Thailand · Pathum Wan, Bangkok · NCT07512856

• See if PrEP Choice helps young people start and stick with HIV prevention methods

  This trial tests whether the PrEP Choice package helps 13-24 year-olds in the U.S. begin and continue using PrEP or DoxyPEP for HIV prevention.

  Recruiting at 6 sites Westat · San Francisco, California and 5 other locations · NCT07510048

• Adding sexual-pleasure conversations to harm reduction services for MSM and transgender people who do chemsex in Thailand

  This project will try using a 'Pleasuremeter' to guide sexual-pleasure conversations in harm reduction services for MSM and transgender people who engage in chemsex or substance use in Thailand to see if it improves sexual health, substance use, and related outcomes.

  Recruiting Institute of HIV Research and Innovation Foundation, Thailand · Pathum Wan, Bangkok · NCT07509853

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.